Results 61 to 70 of about 144 (102)

Pharmacokinetics and safety of high-dose rifampicin in children with TB: the Opti-Rif trial. [PDF]

J Antimicrob Chemother, 2021
Garcia-Prats AJ, Svensson EM, Winckler J, Draper HR, Fairlie L, van der Laan LE, Masenya M, Schaaf HS, Wiesner L, Norman J, Aarnoutse RE, Karlsson MO, Denti P, Hesseling AC.   +13 more
europepmc   +1 more source

Maternal and infant renal safety following tenofovir disoproxil fumarate exposure during pregnancy in a randomized control trial. [PDF]

BMC Infect Dis, 2022
Baltrusaitis K, Makanani B, Tierney C, Fowler MG, Moodley D, Theron G, Nyakudya LH, Tomu M, Fairlie L, George K, Heckman B, Knowles K, Browning R, Siberry GK, Taha TE, Stranix-Chibanda L, PROMISE P1084s Study Team.   +16 more
europepmc   +1 more source

Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant. [PDF]

N Engl J Med, 2021
Madhi SA, Baillie V, Cutland CL, Voysey M, Koen AL, Fairlie L, Padayachee SD, Dheda K, Barnabas SL, Bhorat QE, Briner C, Kwatra G, Ahmed K, Aley P, Bhikha S, Bhiman JN, Bhorat AE, du Plessis J, Esmail A, Groenewald M, Horne E, Hwa SH, Jose A, Lambe T, Laubscher M, Malahleha M, Masenya M, Masilela M, McKenzie S, Molapo K, Moultrie A, Oelofse S, Patel F, Pillay S, Rhead S, Rodel H, Rossouw L, Taoushanis C, Tegally H, Thombrayil A, van Eck S, Wibmer CK, Durham NM, Kelly EJ, Villafana TL, Gilbert S, Pollard AJ, de Oliveira T, Moore PL, Sigal A, Izu A, NGS-SA Group, Wits-VIDA COVID Group.   +52 more
europepmc   +1 more source

The impact of intellectual property protection on the development of digital economy and regional entrepreneurial activity: Evidence from small and medium enterprises. [PDF]

Front Psychol, 2022
Chen H.
europepmc   +1 more source

Brief Report: Impact of ART on Maternal Health After Cessation of Breastfeeding. [PDF]

J Acquir Immune Defic Syndr, 2021
Brummel SS, Taha TE, Angelidou KN, Saidi F, Atuhaire P, Dula D, Moodley D, Matubu A, Chareka G, Nevrekar N, Vhembo T, Fairlie L, Theron G, Mlay P, George K, Basar M, Chakhtoura N, Browning R, Fowler MG, Currier JS, IMPAACT 1077BF/FF PROMISE Study Team.   +20 more
europepmc   +1 more source

Bioprospecting for Rhizobacteria with the Ability to Enhance Drought Tolerance in Lessertia frutescens. [PDF]

Int J Mol Sci, 2023
Hlongwane MM, Dakora FD, Mohammed M, Mokgalaka-Fleischmann NS.   +3 more
europepmc   +1 more source

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial. [PDF]

Lancet HIV, 2021
Madhi SA, Koen AL, Izu A, Fairlie L, Cutland CL, Baillie V, Padayachee SD, Dheda K, Barnabas SL, Bhorat QE, Briner C, Aley PK, Bhikha S, Hermanus T, Horne E, Jose A, Kgagudi P, Lambe T, Masenya M, Masilela M, Mkhize N, Moultrie A, Mukendi CK, Moyo-Gwete T, Nana AJ, Nzimande A, Patel F, Rhead S, Taoushanis C, Thombrayil A, van Eck S, Voysey M, Villafana TL, Vekemans J, Gilbert SC, Pollard AJ, Moore PL, Kwatra G, Wits VIDA COVID team.   +38 more
europepmc   +1 more source

Digital violence against women and children: the state of the literature. [PDF]

Front Sociol
Mbambala TP, Phahlane M.
europepmc   +1 more source

Life Design for Youth as a Creativity-Based Intervention for Transforming a Challenging World. [PDF]

Front Psychol, 2021
Fusco L, Parola A, Sica LS.
europepmc   +1 more source

The Bosadi-Salutogenic framework: culturally embedded identity as a personal resource for work engagement among Black South African women in middle management. [PDF]

Front Psychol
Gift NO.
europepmc   +1 more source